What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Statistics
- Cancer
Barry R. Davis spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Surgery and Chlorthalidone. His Internal medicine research includes themes of Placebo and Endocrinology. His research investigates the link between Cardiology and topics such as Doxazosin that cross with problems in Lipid lowering.
His research integrates issues of Captopril and Ventricular Ejection Fraction in his study of Myocardial infarction. The various areas that he examines in his Surgery study include Clinical trial, Incidence, Rheumatoid arthritis and Confidence interval. His work in Chlorthalidone addresses subjects such as Diabetes mellitus, which are connected to disciplines such as Randomized controlled trial.
His most cited work include:
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels (6753 citations)
- EFFECT OF CAPTOPRIL ON MORTALITY AND MORBIDITY IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION. RESULTS OF THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL (5142 citations)
- Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) (4613 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Cardiology, Chlorthalidone, Blood pressure and Amlodipine. His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Surgery. His Cardiology research is multidisciplinary, incorporating perspectives in Diabetes mellitus, Randomized controlled trial, Disease, Hazard ratio and Risk factor.
His Chlorthalidone research integrates issues from Antihypertensive drug, Atenolol, Doxazosin and Thiazide. His research in Blood pressure intersects with topics in Meta-analysis, Placebo and Emergency medicine. Barry R. Davis interconnects Lisinopril, Calcium channel blocker, Pharmacology and Renal function in the investigation of issues within Amlodipine.
He most often published in these fields:
- Internal medicine (64.84%)
- Cardiology (37.76%)
- Chlorthalidone (25.78%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (64.84%)
- Cardiology (37.76%)
- Blood pressure (26.56%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Cardiology, Blood pressure, Amlodipine and Stroke. Internal medicine is closely attributed to Diabetes mellitus in his work. The study incorporates disciplines such as Clinical trial, Left ventricular hypertrophy, Diuretic, Systolic hypertension and Risk factor in addition to Cardiology.
His biological study spans a wide range of topics, including Meta-analysis, Randomized controlled trial and Disease. His Stroke study combines topics in areas such as Coronary heart disease, Physical therapy, Sickle cell anemia and Prospective cohort study. His Chlorthalidone research is multidisciplinary, relying on both Lisinopril and Cohort.
Between 2013 and 2021, his most popular works were:
- Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174 000 participants in 27 randomised trials (654 citations)
- Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia - TCD with Transfusions Changing to Hydroxyurea (TWiTCH): A multicentre, open-label, phase 3, non-inferiority trial (238 citations)
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (219 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Statistics
- Cancer
Barry R. Davis mostly deals with Internal medicine, Blood pressure, Cardiology, Stroke and Randomized controlled trial. His Internal medicine study frequently links to other fields, such as Diabetes mellitus. Barry R. Davis has researched Cardiology in several fields, including Predictive value of tests, Disease, Diastole and Diuretic.
His Myocardial infarction research incorporates themes from Statin and Physical therapy. His Amlodipine study integrates concerns from other disciplines, such as Chlorthalidone and Risk factor. As a part of the same scientific family, Barry R. Davis mostly works in the field of Chlorthalidone, focusing on Lisinopril and, on occasion, Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
